Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Leguina-Ruzzi A, Cariqueo M
Employers should consider requiring documented diagnoses, evidence-based prior authorization, and stepped therapy, plus lifestyle programs before approving GLP-1s for weight loss to curb long-term spend
People with a history of GI disorders such as IBS, GERD, or gastroparesis Rapid dose escalation moving faster than the recommended 4-week intervals
Circ_0004951 promotes pyroptosis of renal tubular cells via the NLRP3 inflammasome in diabetic kidney disease
US$ 24.16
US$ 23.08
US$ 28.27
US$ 23.10
US$ 28.39
US$ 23.96
US$ 29.27
US$ 29.92
